Month: December 2021

Treg Cell Therapy: A Hotspot in the Field of Immunotherapy

Classification of Treg Cell Therapy The Treg cell therapy (Tregs) is a therapeutic modality based on the mature subpopulation of T-cell therapy that plays a critical role in mediating immunological tolerance to self-antigens and suppress immune responses that are harmful to the host, thereby, enabling homeostasis. These mainly develop in thymus from CD4+ thymocytes and

Site Management Organization: A Trend in the Clinical Trial Domain

Innovators in the pharmaceutical industry are constantly developing ways to improve the process of conducting clinical trial management. Amidst other alternatives, outsourcing various trial operations to a specialized service provider, such as site management organization, has emerged as a viable option for various developers. The advantages of engaging such specialized service providers are numerous and

DNA DATA STORAGE: RESEARCH LANDSCAPE AND FUTURE

DNA data storage involves encoding and decoding binary data to and from synthesized strands of DNA. It offers generous, long-lasting, and stable data storage solution with orders of magnitude relatively higher than current storage mediums. Owing to the numerous benefits offered by DNA data storage as compared to other mediums, it is anticipated that this

HER2 Targeted Therapy: Market Landscape and Future Potential

The epidermal growth factor receptor (EGFR) is a tumor resistance biomarker which plays an essential role in the differentiation and proliferation upon activation through the binding of one of its ligands. A non-ligand-binding member of EGFR family, HER2 exerts its activity through heterodimerisation along with its other family members. HER2 targeted therapy affects the transmembrane

BIOPRESERVATION MEDIA INDUSTRY: A RISING MARKET

Biopreservation is the exclusive biological approach designated for the preservation of cells, tissues and organs ex-vivo for the purpose of storage, shipment and transportation. Biopreservation media is one of the most crucial entity in conferring effectiveness. The selection of the type of media depends upon the considerable time duration desired for the storage, type of

Bioassay Services – A Prerequisite for the ATMPs Development

Bioassay Services – A Prerequisite for the Cell and Gene Therapy Development Over the past few years, investigational new drug (IND) filings by cell and gene therapy companies have significantly increased. In fact, from year 2016 to 2020 more than 300 IND filing for cell and gene therapy product have been recorded, indicating that several